Prediction Case File
YouTubeTracking Live

2 Stocks I'm Buying In The Next 2 Weeks

1 extracted signal · 0 resolved · 1 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
12 Oct 2026, 17:53 UTC
Recorded by Tahlil Plus
12 Oct 2026, 23:03 UTC
Video preview for 2 Stocks I'm Buying In The Next 2 Weeks
Source overview

AI-generated source summary

The analysis focuses on two stocks, CEG and ROAD, with a fundamental outlook. For CEG, the current price is $298.07, with a target price of $571.32, suggesting a bullish outlook. The fail bound is set at $286.00, indicating that a price below this level would invalidate the bullish thesis. The stock is currently exhibiting a bearish trend, but the analysis predicts a bullish future. For ROAD, the current price is $86.81, with a target price of $100.00, also suggesting a bullish prediction. The fail bound is $70.00, below which the bullish outlook would be invalidated. The stock is currently in a bearish trend, but the prediction is bullish. The analysis for CEG is based on its strong position in the utility sector, significant nuclear power generation capacity, and lucrative long-term contracts with tech giants like Google and Amazon. These contracts provide a stable revenue stream and a floor for pricing power, despite the company's current bearish trend. The company's ability to secure such deals and its operational advantages, like a large nuclear fleet, suggest strong future growth potential. The valuation model for CEG shows an expected upside potential based on projected earnings growth and a conservative P/E ratio, indicating it is currently undervalued despite the recent stock performance. For ROAD, the analysis highlights its role in infrastructure development, benefiting from government funding programs and bipartisan support for reauthorization. The company's business model, focused on essential services like asphalt production and road maintenance, provides consistent demand. The company's strong backlog and consistent organic growth rate further support a bullish outlook, despite its current bearish trend. The acquisitions made by the company at attractive multiples also contribute to its long-term value proposition. The analysis suggests that while the stock may appear to be in a bearish trend, its underlying fundamentals and future growth catalysts present a compelling opportunity.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. Source processing completed

    Source analysis and structured extraction completed.

  6. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.5
Tracked signals
358
Historical success
34.3%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail